Thyroid hormone receptor-β (TRβ1) impairs cell proliferation by the transcriptional inhibition of cyclins D1, E and A2

Oncogene

Volumn 27, Issue 19, 2008, Pages 2795-2800

  Porlan, E ^a   Vidaurre, O G ^a   Rodriguez Pena A ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

AP 1; Cell cycle; Cyclins; E2F 1; Nuclear receptors; Thyroid hormone receptor

Indexed keywords

CYCLIN A2; CYCLIN D1; CYCLIN E; CYCLINE; MESSENGER RNA; PROTEIN C JUN; RETINOBLASTOMA PROTEIN; THYROID HORMONE RECEPTOR BETA; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL CYCLE; CELL CYCLE PROGRESSION; CELL DIVISION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; CELL PROLIFERATION; CYCLIN A; CYCLIN D1; CYCLIN E; CYCLINS; DOWN-REGULATION; GROWTH INHIBITORS; MICE; NIH 3T3 CELLS; SWISS 3T3 CELLS; THYROID HORMONE RECEPTORS BETA; TRANSCRIPTION, GENETIC;

EID: 42549092094     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210936     Document Type: Article

References (31)

1. Barrera-Hernandez G, Zhan Q, Wong R, Cheng SY. (1998). Thyroid hormone receptor is a negative regulator in p53-mediated signaling pathways. DNA Cell Biol 17: 743-750.
2. Benkoussa M, Brand C, Delmotte MH, Formstecher P, Lefebvre P. (2002). Retinoic acid receptors inhibit AP1 activation by regulating extracellular signal-regulated kinase and CBP recruitment to an AP1-responsive promoter. Mol Cell Biol 22: 4522-4534.
3. Bhat MK, Yu C, Yap N, Zhan Q, Hayashi Y, Seth P et al. (1997). Tumor suppressor p53 is a negative regulator in thyroid hormone receptor signaling pathways. J Biol Chem 272: 28989-28993.
4. Botz J, Zerfass-Thome K, Spitkovsky D, Delius H, Vogt B, Eilers M et al. (1996). Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter. Mol Cell Biol 16: 3401-3409.
5. Campanero MR, Armstrong MI, Flemington EK. (2000). CpG methylation as a mechanism for the regulation of E2F activity. Proc Natl Acad Sci USA 97: 6481-6486.
6. Chan IH, Privalsky ML. (2006). Thyroid hormone receptors mutated in liver cancer function as distorted antimorphs. Oncogene 25: 3576-3588.
7. Chassande O, Fraichard A, Gauthier K, Flamant F, Legrand C, Savatier P et al. (1997). Identification of transcripts initiated from an internal promoter in the c-erbA alpha locus that encode inhibitors of retinoic acid receptor-alpha and triiodothyronine receptor activities. Mol Endocrinol 11: 1278-1290.
8. Deogracias R, Espliguero G, Iglesias T, Rodriguez-Pena A. (2004). Expression of the neurotrophin receptor trkB is regulated by the cAMP/CREB pathway in neurons. Mol Cell Neurosci 26: 470-480.
9. Furumoto H, Ying H, Chandramouli GV, Zhao L, Walker RL, Meltzer PS et al. (2005). An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/ E2F pathway and induces pituitary tumorigenesis. Mol Cell Biol 25: 124-135.
10. Garcia-Silva S, Aranda A. (2004). The thyroid hormone receptor is a suppressor of ras-mediated transcription, proliferation, and transformation. Mol Cell Biol 24: 7514-7523.
11. Glass CK, Rosenfeld MG. (2000). The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14: 121-141.
12. Gonzalez-Sancho JM, Garcia V, Bonilla F, Munoz A. (2003). Thyroid hormone receptors/THR genes in human cancer. Cancer Lett 192: 121-132.
13. Gottlicher M, Heck S, Herrlich P. (1998). Transcriptional cross-talk, the second mode of steroid hormone receptor action. J Mol Med 76: 480-489.
14. Hashimoto K, Curty FH, Borges PP, Lee CE, Abel ED, Elmquist JK et al. (2001). An unliganded thyroid hormone receptor causes severe neurological dysfunction. Proc Natl Acad Sci USA 98: 3998-4003.
15. Koenig RJ, Lazar MA, Hodin RA, Brent GA, Larsen PR, Chin WW et al. (1989). Inhibition of thyroid hormone action by a non-hormone binding c-erbA protein generated by alternative mRNA splicing. Nature 337: 659-661.
16. Krude T, Jackman M, Pines J, Laskey RA. (1997). Cyclin/Cdk-dependent initiation of DNA replication in a human cell-free system. Cell 88: 109-119.
17. Le Cam L, Polanowska J, Fabbrizio E, Olivier M, Philips A, Ng Eaton E et al. (1999). Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex. EMBO J 18: 1878-1890.
18. Lin HM, Zhao L, Cheng SY. (2002). Cyclin D1 Is a ligandin-dependent co-repressor for thyroid hormone receptors. J Biol Chem 277: 28733-28741.
19. Nygard M, Wahlstrom GM, Gustafsson MV, Tokumoto YM, Bondesson M. (2003). Hormone-dependent repression of the E2F-1 gene by thyroid hormone receptors. Mol Endocrinol 17: 79-92.
20. O'Shea PJ, Williams GR. (2002). Insight into the physiological actions of thyroid hormone receptors from genetically modified mice. J Endocrinol 175: 553-570.
21. Pfaffl MW. (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: 45.
22. Pfahl M. (1993). Nuclear receptor/AP-1 interaction. Endocr Rev 14: 651-658.
23. Porlan E, Vega S, Iglesias T, Rodriguez-Pena A. (2004). Unliganded thyroid hormone receptor beta1 inhibits proliferation of murine fibroblasts by delaying the onset of the G1 cell-cycle signals. Oncogene 23: 8756-8765.
24. Rayman JB, Takahashi Y, Indjeian VB, Dannenberg JH, Catchpole S, Watson RJ et al. (2002). E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/ mSin3B corepressor complex. Genes Dev 16: 933-947.
25. Sanz-Gonzalez SM, Castro C, Perez P, Andres V. (2004). Role of E2F and ERK1/2 in STI571-mediated smooth muscle cell growth arrest and cyclin A transcriptional repression. Biochem Biophys Res Commun 317: 972-979.
26. Shaulian E, Karin M. (2001). AP-1 in cell proliferation and survival. Oncogene 20: 2390-2400.
27. Sherr CJ. (1995). Mammalian G1 cyclins and cell cycle progression. Proc Assoc Am Physicians 107: 181-186.
28. Wisdom R. (1999). AP-1: one switch for many signals. Exp Cell Res 253: 180-185.
29. Yamaguchi K, Lantowski A, Dannenberg AJ, Subbaramaiah K. (2005). Histone deacetylase inhibitors suppress the induction of c-Jun and its target genes including COX-2. J Biol Chem 280: 32569-32577.
30. Yap N, Yu CL, Cheng SY. (1996). Modulation of the transcriptional activity of thyroid hormone receptors by the tumor suppressor p53. Proc Natl Acad Sci USA 93: 4273-4277.
31. Zhang J, Lazar MA. (2000). The mechanism of action of thyroid hormones. Annu Rev Physiol 62: 439-466.